Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEPW) Equity Ratio (2021 - 2025)

Coeptis Therapeutics Holdings has reported Equity Ratio over the past 5 years, most recently at 0.87 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.87 for Q4 2025, up 129.39% from a year ago — trailing twelve months through Dec 2025 was 0.87 (up 129.39% YoY), and the annual figure for FY2025 was 0.87, up 129.39%.
  • Equity Ratio for Q4 2025 was 0.87 at Coeptis Therapeutics Holdings, up from 0.73 in the prior quarter.
  • Over the last five years, Equity Ratio for COEPW hit a ceiling of 0.87 in Q4 2025 and a floor of 0.29 in Q1 2024.
  • Median Equity Ratio over the past 5 years was 0.24 (2022), compared with a mean of 0.26.
  • Biggest five-year swings in Equity Ratio: tumbled 305.63% in 2024 and later surged 886.37% in 2025.
  • Coeptis Therapeutics Holdings' Equity Ratio stood at 0.35 in 2021, then skyrocketed by 61.93% to 0.56 in 2022, then crashed by 68.35% to 0.18 in 2023, then surged by 113.2% to 0.38 in 2024, then soared by 129.39% to 0.87 in 2025.
  • The last three reported values for Equity Ratio were 0.87 (Q4 2025), 0.73 (Q3 2025), and 0.58 (Q2 2025) per Business Quant data.